Daniel Sindelar DMD

Daniel Sindelar DMD serves as the CEO of Keystone Bio, a leader in oral systemic health, since August 2017. As the Founder and Director of Oral Genomics, LLC, since 2011, Daniel Sindelar has been instrumental in establishing the link between oral pathogens and systemic diseases, particularly cardiovascular disease. Previously, Daniel Sindelar was the President of Sindelar Dental from June 1981 to July 2017, focusing on advanced cosmetic rehabilitation and various dental therapies. Additionally, as a co-founder and past president of the American Academy for Oral Systemic Health, Daniel Sindelar has contributed significantly to the global understanding of oral health's impact on overall health. Daniel Sindelar's educational background includes an Executive Management Program in Finance from Harvard Business School Online and a DMD from Washington University in St. Louis School of Dental Medicine.